Pure Global
NCT06313827

e-Health Program to Prevent Exacerbations in the Cystic Fibrosis Population

Effectiveness of an e-Health Program to Prevent Exacerbations in the Cystic Fibrosis Population: a Randomized Clinical Trial
University of Valencia·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Cystic Fibrosis
Drug/Device/Intervention
Exercise plus Monitoring Group (TG-2)
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of Valencia
Location
Valencia, Spain
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2024
End date
Jun 01, 2025
Enrollment
60 participants
Primary outcome

Clinical exacerbation

Summary

The goal of this clinical trial is to analyse the impact of a telematic assessment and
 monitoring protocol in people with cystic fibrosis, in order to identify exacerbations early,
 thus preventing loss of lung function and maintaining quality of life.
 
 Participants will be assigned to one of 3 study groups:
 
 Control group (CG-1): will receive their usual physiotherapy treatment; Treatment group
 (TG-2): will receive their usual physiotherapy treatment, plus explanation of the use of the
 monitoring equipment; Treatment and follow-up group (TGF-3): will receive their usual
 physiotherapy treatment, plus explanation of the use of the monitoring equipment, plus
 telematic control of exacerbations with feedback from the physiotherapist.

ICD-10 classifications
Cystic fibrosisCystic fibrosis, unspecifiedCystic fibrosis with other manifestationsCystic fibrosis with pulmonary manifestationsCystic fibrosis with intestinal manifestations
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06313827
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06313827 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Valencia and is currently Not yet recruiting. The study focuses on Cystic Fibrosis. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.